Bococizumab is a cutting-edge anti-PCSK9 antibody effectively developed to combat hypercholesterolemia. It therapeutic agent works by the PCSK9 protein, a key regulator of cholesterol concentrations. By neutralizing https://bookmarks-hit.com/story25229010/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia